Ginger: 109 Trials, and What They Were About

A plain guide, written to be useful before you spend anything.

What this actually means

A systematic review covering 109 randomised controlled trials of ginger found the most consistent results for certain kinds of nausea, with inflammatory and metabolic endpoints much weaker. That definition matters because the term gets used loosely in supplement marketing, where a real mechanism is routinely stretched into a promise the evidence does not carry.

Ginger is genuinely well studied, which makes it a good case study in how research volume gets borrowed for unrelated claims.

Why it matters if you are buying a supplement

Almost every purchase decision in this category comes down to one question: is the product addressing the actual cause of the problem you have? Appetite, sleep debt, an energy surplus, insulin resistance and simple measurement error all produce similar-looking frustration, and they need different responses. Getting the cause right is worth more than getting the product right.

Ginger is genuinely well studied, which makes it a good case study in how research volume gets borrowed for unrelated claims. That is why the sequence on this site is always the same — understand the mechanism, check the dose against the research, then decide whether a product is buying you anything.

Four things worth knowing

• 109 RCTs is a substantial research base.
• The strongest findings concern nausea.
• Other endpoints range from very low to moderate certainty.
• Trials use gram-level doses.

What to do about it

1. Match the claim to the endpoint the trials studied.
2. Check the dose against the gram-level trial range.
3. Do not read nausea research as respiratory evidence.
4. Note the bleeding-risk interaction if on anticoagulants.

Several of those cost nothing, which is the point. For breathing the interventions with the strongest evidence — getting a persistent symptom diagnosed, not smoking, taking prescribed inhalers as directed, reducing air-pollution exposure — are consistently cheaper and far less marketed than any spray.

One more framing point. Effect sizes in this field are usually small, and small effects are exactly the ones personal impression cannot detect — especially where expectation does as much work as it does in this category. A written record beats a memory every time.

It is also worth separating what is measurable from what is marketable. The interventions with the strongest evidence here rarely have a product attached, which tells you something about why you hear about them least.

If you take prescription medication, run any new supplement past a pharmacist first. It takes minutes, it is usually free, and a fully printed label makes the answer immediate.

The myth to drop

That a large research base for one endpoint supports every claim.

For background reading from sources with nothing to sell, see American Lung Association and NHLBI — COPD.

Where Breathizen fits

Breathizen sale pricing is a respiratory-support oral spray taken as four pumps once daily. The brand publishes five botanicals — mullein leaf extract 10:1, ginger root extract, bromelain powder, organic lemon extract and organic Cordyceps militaris — inside a single 154 mg blend with no individual amounts. The page selling it lists seven.

Read against this topic, the honest placement is as a small daily botanical intake rather than a respiratory remedy. The ingredients are real and the brand is unusually candid about their evidence — but the spray is swallowed rather than inhaled, so nothing reaches the airway, and 154 mg split five ways is far below every studied dose. It belongs alongside a doctor's assessment of any breathing symptom, never in place of it, and never in place of a prescribed inhaler. The detail is on the Breathizen benefit verdicts.

Questions readers ask